Endomyocardial Fibrosis: Clinical Trials

6 trials for Endomyocardial Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1

Follow Endomyocardial Fibrosis: new trials by email Literature Review of Endomyocardial Fibrosis trials Research Report on Endomyocardial Fibrosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The COlchicine HypERtENsion Trial
Colchicine, Placebo - Hypertension
Phase 2Active not recruitingHerlev and Gentofte Hospital1502021-08-102025-12-22
Right Ventricle Remodeling After Pulmonary Valve Replacement and Percutaneous Pulmonary Valve Insertion
Endomyocardial Fibrosis, Pulmonary Valve Stenosis
CompletedUMC Utrecht262016-02-012021-10-22
The Genetic Basis of Acquired Heart Disease in Africa
Rheumatic Heart Disease, Rheumatic Fever
CompletedNational Human Genome Research Institute (NHGRI)7362014-04-032020-02-13
Assessment of Myocardial Fibrosis in Aortic STenosis
Endomyocardial Fibrosis, Aortic Valve Stenosis
CompletedOdense University Hospital1122014-03-012017-04-04
Left Atrial Volume Index in Asymptomatic Aortic Stenosis
Aortic Valve Stenosis, Heart Failure
CompletedOdense University Hospital1002014-01-012016-09-27
Spironolactone in Adult Congenital Heart Disease
Spironolactone 25mg, Placebo - Congenital Heart Disease, Heart Failure
Phase 2CompletedOregon Health and Science University402010-02-012019-08-21

Narrower conditions

Aortic Valve Stenosis (2)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Heart Failure (2)  ·  Hypertrophy, Left Ventricular (2)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Cardiomyopathies (1)  ·  Coronary Artery Disease (1)  ·  Fibrosis (1)  ·  Heart Defects, Congenital (1)  ·  Heart Valve Diseases (1)  ·  Hypertension (1)  ·  Hypertrophy (1)

Broader conditions

Cardiomyopathies (5)  ·  Cardiovascular Diseases (4)  ·  Heart Diseases (4)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Ventricular Outflow Obstruction (3)  ·  Aortic Valve Disease (2)  ·  Cardiomegaly (2)  ·  Heart Valve Diseases (2)  ·  Pathological Conditions, Anatomical (2)  ·  Arrhythmias, Cardiac (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Arthritis (1)  ·  Bacterial Infections (1)

Interventions

Colchicine (1)  ·  Spironolactone (1)

Sponsors

Odense University Hospital (2)  ·  Herlev and Gentofte Hospital (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  Oregon Health and Science University (1)  ·  UMC Utrecht (1)

Countries

Denmark (3)  ·  Netherlands (1)  ·  Nigeria (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Craig Broberg, MD (1)  ·  Jordi S Dahl, MD PhD (1)  ·  Jordi S Dahl, MD, Ph.D. (1)  ·  Lars M Rasmussen, MD PhD DMsc (1)  ·  Michiel Voskuil, MD, PhD (1)  ·  Niklas Dyrby Johansen, MD (1)  ·  Paul S Kruszka, M.D. (1)

Results publications

PMID 33574022, PMID 27894069, PMID 29222121, PMID 30977792, PMID 36356959, PMID 41730521, PMID 42210033

NIH funding

K23HL093024 (1)